摘要
目的观察61例适宜于二尖瓣球囊扩张合并心房颤动患者及11例合并左心房血栓的患者进行华法令（3mg／d）抗凝治疗的效果。方法所有房颤及左心房血栓均由经食道超声心动图证实和随访。随访期间定期复查超声心动图、凝血酶原时间n结果对61例合并房颤而未发现左房血栓者华法令抗凝3个月后行二尖瓣球囊扩张无一例栓塞事件发生。合并左心房血栓者行华法令抗凝6个月opg％血栓消失。结论对合并房颤的风湿性心脏病二尖瓣狭窄患者常规华法令抗凝3个月后再行二尖瓣球囊扩张可减少栓塞并发症的发生。对合并在房血栓患者抗凝时间以血栓消失为标准，华法令（3mg／d）抗凝安全可靠，以6个月为宜。
To observe the effects of anti-coagulation action of Warfarin treatment (3mg/d) on61 cases having indications of PBMV accompaning with atrial fibillation and 11 cases with left atrial thrombosisMethods: All the patients with atrial fibrillation and left atrial thrombosis were demonstrated by echocardiogram through esophagus and followed-up. TEE and PT were examined on times during following-up. Results: No embolismocurred on 61 cases accompaning with artial fibrillation but without thrombosis who were performed PBMV after 3months of anti-coagulation action of Warfarin; 90.9% thrombosis disappeared on the patients with left atrial throm thrombosis who were performed PBMV after 6 months of anti-coagulation action of Warfarin. Conclusion:Complications ofembolism after PBMV can be reduced with 3 months of anti-coagulation of Warfarin routinely on patients with mitral valve stenosis and reuthmatic heart disease accompaning with artial fibrillation. Disappearing of thrombosis is regardedas our standard of anti-coagulation time for patients with left atrial thrombosis. The anticoagulation effect of Warfarin(3mg/d) is safe and dependable, usually 6 months is adequate.
出处
《泰山医学院学报》
CAS
1998年第4期299-301,共3页
Journal of Taishan Medical College
关键词
二尖瓣球囊扩张
华法令
并发症
预防
栓塞
percutaneous ballon mitral valvuloplasty (PBMV)
Warfarin
embolism
